Tweet by Michael “Mike” Albert, MD on Twitter Posted byJoseph Thornton MDMay 21, 2022Posted inBlog Michael “Mike” Albert, MD @MichaelAlbertMD This is remarkable as tirzepatide (Mounjaro) produces ~40% more weight loss and ~40% greater reductions in A1c than Wegovy (semaglutide). 5/21/22, 9:45 AM Joseph Thornton Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Like Loading... Related Published by Joseph Thornton MD Teacher, Clinical Supervisor, [AIdvisor] Retired Clinical Associate Professor, Psychiatry, University of Florida Affiliation is for identification only. All content and opinions are my own. View more posts
Gator Psychiatry 